Piper Sandler Maintains Neutral on Elanco Animal Health, Raises Price Target to $12-Report released on 12th Nov 2023
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst David Westenberg has maintained a Neutral rating on Elanco Animal Health (NYSE:ELAN) and increased the price target from $11 to $12 as reported on November 12, 2023.
November 13, 2023 | 9:23 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Piper Sandler has maintained a Neutral rating on Elanco Animal Health and raised the price target from $11 to $12.
The increase in price target by Piper Sandler suggests a positive outlook on Elanco Animal Health's stock value in the short term. While the rating remains Neutral, the higher price target may lead to increased investor confidence and a potential uplift in the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100